QUATTRO THERAPY - clinically proven pressure relief, lower interface pressures and enhanced comfort.
During the 1-in-4 Active cell cycle the patient is supported on at least 75% of the mattress surface at all times whilst the pressure on 25%
of the body is relieved. This provides a higher level of comfort and lower average support pressures compared to 2 or 3 cell cycle systems, together with increased patient compliance.
Continuous Low Pressure Therapy - optimum pressure distribution.
When in Continuous Low Pressure therapy mode pressure is equalised within the cells, allowing greater immersion into the mattress surface and optimum pressure distribution.
TISSUEgard air cell technology
The unique patented TISSUEgard air cell design features a pleated surface giving up to 15% additional support area, allowing the patient to immerse into the mattress, virtually eliminating lateral tension in the mattress surface. This results in reduced pressures, shear and friction, the key contributory factors to tissue damage, and alleviates the need for a dedicated heel zone.
AUTOsupport - fully automatic pressure adjustment.
AUTOsupport feature automatically adjusts pressure within each of the cells throughout the cycle so that support, posture and therapy are constantly maintained at optimum levels, in response to patient weight, movement and position. Equalisation of cell pressure automatically takes place at each stage of the cycle, again to ensure precise pressure and therapy is applied.
ODS cell design for optimum patient support and security
Air cells feature ortho-differential support (ODS) which provides optimum internal cell pressures for varying body weights and shapes, automatically compensating for the patient’s BMI. Narrower in the centre than at the outer edge, air cells feature in-built support pressure differential, supporting the smaller, lighter patient on the softer central area of the cell, and the larger, heavier patient on the firmer outer edges, as well as providing a feeling of security for the patient.